QuantRank
Back to ranking
#238USNYSE

DVA

DaVita

$181.66USD

Data as of 2026-09-05

Fair value$491.81
Target$576.00
Loss chance13%Low

Company attributes

SizeLarge cap
SectorHealth Care
Dividend—
TypeCommon stock

Price

Interactive 5-year price history chart for DVA. Latest close $181.66.

Loading price history…

Pillar breakdown

0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)

Health Care median (n=163)
  • Quality
    Profit margins & asset efficiency
    36
    Weak
    Health Care median (n=163) 51
  • Value
    Price vs fundamentals
    84
    Exceptional
    Health Care median (n=163) 51
  • Growth
    Revenue & earnings trajectory
    60
    Strong
    Health Care median (n=163) 50
  • Momentum
    Recent price strength
    72
    Exceptional
    Health Care median (n=163) 62
  • Health
    Balance sheet & solvency
    55
    Strong
    Health Care median (n=163) 56
  • Profitability
    ROE, ROA, ROIC
    59
    Strong
    Health Care median (n=163) 49
  • Technical
    Trend & volatility signals
    72
    Exceptional
    Health Care median (n=163) 62
  • Risk
    Volatility & drawdown profile
    58
    Strong
    Health Care median (n=163) 47
025405570100
Exceptional (70+)Strong (55–70)Average (40–55)Weak (25–40)Poor (<25)

Pillars not shown: Sentiment, ML (Phase 5+).

Fair price check

3 different valuation methods each estimate what DVA should be worth, then we compare to today's price.

Looks undervalued
Models suggest DVA is trading below fair value
Today's price
$181.66
Median fair price
$491.81
+171% vs today's price
Of 3 methods:2 say cheap1 say pricey
  • EV/EBITDAUndervalued
    thinks it's a bargain — estimates $576.00, about 217% above today
  • P/E multiplesUndervalued
    thinks it's a bargain — estimates $491.81, about 171% above today
  • DCF (2-stage)Overvalued
    thinks it's expensive — estimates $140.86, about 22% below today

How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.

Fair price ensemble

Median fair
$491.81
Margin of safety(vs fair value)
+63.1%
Max (ex-outliers)
$576.00
Tangible BVPS
—

Median of all applicable methods (current price $181.66). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.

Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.

Supporting dataRaw fundamentals & data-quality provenance behind the scores above

Raw fundamentals (SEC EDGAR)

MetricValue
Market cap$11.59B
Revenue (TTM)$14.01B
Net income (TTM)$1.19B
Operating cash flow (TTM)$2.19B
CapEx (TTM)$583.35M
Free cash flow (TTM)CFO − CapEx$1.61B
Total assets$17.71B
Total liabilities$16.63B
Stockholders' equity$-765.10M
Cash & equivalents$668.96M
Shares outstanding63.80M
EPS (basic)$18.64
EPS (diluted)$18.64
P/E ratio (TTM)9.74

TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).

Data quality

Latest filed date
2026-08-04
Latest period end
2026-07-31
Filing lag
32 days
Missing metrics
5(gross_profit, cost_of_revenue, research_and_development, interest_expense, dividends_paid)

Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.